Some Nrf2 inhibitors have been found with anti-cancer efficacy by suppressing Nrf2 expression, causing Nrf2 degradation or inhibiting Nrf2 nuclear translocation (Qin et al., 2019). Here, NFE2L2 is linked to cancer.